Masakazu Gonda
Papers
4
Total Citations
15
H-Index
3
About
Masakazu Gonda is a urologic surgeon and researcher whose work centers on improving outcomes for prostate cancer patients, particularly through the refinement of robot-assisted surgical techniques and the exploration of non-toxic chemopreventive agents. His most impactful study, with 6 citations, uses cumulative sum analysis to define the learning curve for multiple surgeons performing robot-assisted radical prostatectomy (RARP), providing critical benchmarks for surgical training and quality assurance. Gonda has also contributed to the growing field of active surveillance, presenting preliminary evidence (4 citations) on the safety and clinical efficacy of luteolin, a natural flavonoid, as a potential therapeutic for patients with prostate cancer—addressing the urgent need for effective, low-toxicity interventions. His work extends to post-surgical quality of life, where he identified the postoperative bladder neck-to-pubic symphysis ratio as a predictive factor for de novo overactive bladder after RARP, and to rare oncologic cases, such as clear cell carcinoma in a female urethral diverticulum. Through these diverse contributions, Gonda demonstrates a commitment to advancing both surgical precision and holistic patient care in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3A rare case of a clear cell carcinoma in a female urethral diverticulum3 citations · 2022
- 4